• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number RLT281218
Device Problem Fluid/Blood Leak (1250)
Patient Problem Hemorrhage/Bleeding (1888)
Event Date 02/08/2024
Event Type  malfunction  
Manufacturer Narrative
W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following was reported to gore: on (b)(6) 2024, a patient was implanted with a 28mm x 18cm gore® excluder® aaa endoprosthesis with c3® delivery system (excluder device) to treat abdominal aortic aneurysm and iliac artery aneurysm.The physician found there was blood infusion into catheter handle and 100ml blood leakage.The physician hurried deployment to avoid continuous leakage.The postoperative patient had low hemoglobin and received a 200ml blood transfusion.
 
Manufacturer Narrative
H6: c19 - a review of the manufacturing records indicated the lot met pre-release manufacturing specifications.The device evaluation showed the following: o engineering removed the handle covers and the spine was examined.The manifold assembly contained dried blood.The septum appeared to be intact with no obvious damage.The glue ports were inspected and appeared to be filled with glue and cured.O purple dyed water was pressurized through the septum into the manifold area to determine the location of the leakage.Purple dyed water was observed externally, towards the nose of the manifold.O a closer inspection near the leak was done and insufficient glue was observed under the catheter in the nose of the spine.Based on the findings from this evaluation, the observation ¿there was blood infusion into catheter handle¿ was confirmed.However, neither the rate nor total amount of the leakage could not be determined.The likely cause for the observed leakage was an incomplete seal caused by an insufficient amount of glue in the nose of the manifold.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL PHOENIX 1 B/P
32360 n. north valley parkway
phoenix AZ 85085
Manufacturer Contact
pixie xi
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18764872
MDR Text Key336532831
Report Number3007284313-2024-03066
Device Sequence Number1
Product Code MIH
UDI-Device Identifier00733132622511
UDI-Public00733132622511
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRLT281218
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2024
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/08/2024
Initial Date FDA Received02/23/2024
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received04/25/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/21/2024
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age85 YR
Patient SexMale
Patient Weight55 KG
-
-